Immunotherapy Advances in Small Cell Lung Cancer

Cancerresearch

Small cell lung cancer (SCLC) is aggressive and often difficult to treat, but many patients may have new hope. On August 17, 2018, the FDA approved the first immunotherapy the checkpoint inhibitor nivolumab (Opdivo, Bristol-Myers Squibb for patients with small cell lung cancer. Since this approval, there has been renewed focus on how to make different immunotherapies work for a disease which typicallly comprises 10-15% of all lung cancer cases. In this webinar for patients and caregivers, Matthew Hellmann, M.D., of Memorial Sloan Kettering Cancer Center discusses the new FDA approval, clinical trials, and potential treatments for patients with small cell lung cancer.
Watch Now

Spotlight

Serving as Mother Teresa's personal physician late in her life inspired Dr. Devi Shetty to create an affordable-health-care system for the poor. The company he founded, Narayana Health, now operates 32 hospitals across India.

OTHER ON-DEMAND WEBINARS

2019 Top Ten Trends in Healthcare

healthstream

2019 will be a year of change in the healthcare industry but also a great innovation. In this webinar, we will identify ways to help your organization face the year head-on, while also addressing challenges that are influencing the delivery of care.
Watch Now

Leveraging Modern Data Center Technologies to Boost EHR Performance

HIMSS Media

With the widespread digitization of patient health records, traditional paper and film-based records have been replaced with Electronic Health Records (EHRs). Whether your organization is a large clinical practice with multiple locations, a single facility hospital, or an accountable care organization, EHR solutions can help you streamline workflows and improve your ability to care for patients. But to make the most of today’s innovative EHR offerings, IT teams often resort to piecing together custom infrastructure solutions using separate servers and storage in order to deal with the need for improved application performance.
Watch Now

Health Care in the Age of Social Media

lorman

Learn how to better identify any liability and regulatory risks that may occur on social media. Social media seems to be part of every aspect of our lives, and health care is no exception. In the health care industry, professionals dealing with social media confront unique and critical compliance pitfalls like privacy, security, and HIPAA concerns. This topic will go over how to navigate key compliance issues, such as using social media for marketing, setting social media policies for employees, ownership of social media content, social media as part of the medical record, and how to identify risks and mitigate them by setting up appropriate social media policies. This information will give you the insights and tools you need to identify and minimize regulatory and liability risks linked to social media, and draft your own social media policy using a sample policy and put into place appropriate consequences for potential violations.
Watch Now

De-risk therapeutic antibody drug development using humanized fcrn mice

Jax

Do you need reliable pharmacokinetic data (PK) to evaluate human immunoglobulin or albumin-based therapeutic drug candidates? The humanized FcRn (Hu-FcRn) mouse model enables you to obtain clinically-relevant PK data related to drug half-life. This critically important PK data helps optimize the design of preclinical efficacy studies and to de-risk lead selection.
Watch Now